The Hon John Brumby
Chairman and Director
The Hon John Brumby was the former Premier of Victoria, Australia (2007 – 2010) and has immense experience in public life serving for more than 10 years as Treasurer and then Premier of Victoria, as well as seven years in the Federal Parliament as a member of the Hawke Government.
In Government, Mr Brumby was a champion of science, technology and innovation with major new investments in the Australian Synchrotron, the new Florey Neuroscience Centre, the $250 million BioResource Centre, the Australian Centre for Regenerative Medicine, the expansion of WEHI and the new $1 billion Victorian Comprehensive Cancer Centre.
Since retiring from politics, Mr Brumby has continued his active support for innovation and medical research, Chairs a number of for profit and not for profit organisations and is widely published on a range of issues.
Mr Ben-Meir is the inaugural Executive Director of Research, Innovation and Commercialisation at the University of Melbourne and CEO of UoM Commercial Ltd, with overall responsibility for all research funding, external commercial engagements and the commercialisation of University generated intellectual property. Mr Ben-Meir has extensive experience in the venture capital industry and commercialisation more generally and has held previous roles including the inaugural CEO of Commercialisation Australia and Director of the Entrepreneurs’ Infrastructure Programme.
Mr Ben-Meir’s qualifications include a Bachelor of Science and a Bachelor of Electrical and Computer Systems Engineering (1st Class Honours) from Monash University, Melbourne. He is also a graduate member of the Australian Institute of Company Directors.
Mr Ken Sloan is the Deputy Vice-Chancellor and Vice-President (Enterprise) at Monash University with overall responsibility for providing University-wide leadership and strategic support for industry partnerships, commercialisation, industry engagement, innovation and student entrepreneurship, employability and work experience.
Mr Sloan has had extensive international experience in business development and commercialisation, university administration and leadership. Mr Sloan has previously held roles as the Chief Operating Officer at the University of Warwick, as a Business Development Director, with International Services Company SERCO, and has served as an advisor to the Stephen A. Schwarzman Education Foundation based at Tsinghua University in Beijing. He has chaired and served on the boards of a number of institutional subsidiary Companies and international development trusts.
Mr Sloan’s qualifications include an MA from the University of Glasgow, an MBA from the Warwick Business School and is a member of CPA Australia.
Chief Executive Officer
Dr C. Glenn Begley is a clinical haematologist and medical oncologist, whose academic and commercial roles include board level and senior positions in Australia, the USA and the UK. Most recently DrBegley was Chief Scientific Officer at Akriveia Therapeutics, a Californian biotech company focused on discovering and developing the next generation of cancer immunotherapies. He was also a non-Executive Director for UK-based Oxford BioTherapeutics.
His previous roles include:
- Chief Scientific Officer and Senior Vice-President, TetraLogic Pharmaceuticals (Pennsylvania)
- Vice-President and Global Head, Hematology and Oncology Research, Amgen (California)
- Executive Director, Western Australian Institute of Medical Research (Perth)
- Senior Principal Research Fellow and Professor of Medicine, Walter and Eliza Hall Institute of Medical Research, University of Melbourne
Dr Begley studied Medicine at undergraduate and postgraduate level at The University of Melbourne.
Chief Operating Officer (Interim)
Company Secretary (Interim)
Linda Peterson is the Interim COO for BioCurate Pty Ltd, responsible for the set-up of the company and to ensure its operational arrangements are in place for the CEO and management team to commence business in 2017. Ms Peterson has extensive experience in the biomedical sector, leading and managing new initiatives, multidisciplinary teams and R&D projects. She is the Principal of her consulting business Linda Peterson and Associates and previous roles include the CEO of Bionic Enterprises Pty Ltd and Executive Manager of the Bionics Institute.
Linda’s qualifications include a Bachelor of Biological Sciences and post graduate qualifications in business administration.